Las Vegas, NV -- (SBWIRE) -- 12/09/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: OCZ Technology Group Inc. (NASDAQ:OCZ), Metabolix, Inc. (NASDAQ:MBLX),Amarin Corporation plc (ADR) (NASDAQ:AMRN), Delcath Systems, Inc. (NASDAQ:DCTH)
OCZ Technology Group Inc. (NASDAQ:OCZ) managed to keep its gain at 7.91% on above-normal volume of 8.18M shares. The stock settled at $0.109 after floating in a range of $0.10 to $0.12. Its latest price has reached market capitalization of $7.44 million. Its 52-week range has been $0.09 to $2.77. OCZ Technology Group, Inc. (OCZ) designs, manufactures, and distributes solid-state drives (SSDs) and computer components. OCZ designs and manufactures SSDs in a variety of form factors and interfaces including Serial advanced technology attachment (SATA), serial-attached small computer system interface (SAS), peripheral component interconnect express (PCIe), as well as the development of flash management software, caching and virtualization software. The Company is also a provider of flash controller silicon and firmware for SSDs. In addition to SSD technology, OCZ offers power management products.
For How Long OCZ will fight for Profitability? Read This Trend Analysis report
Metabolix, Inc. (NASDAQ:MBLX) traded up on a volume of 4.51 million, higher than its standard daily volume. Shares have gained 52.34% to $1.63. Over the last twelve months, the stock has lost-9.44% and faced a worst price of $0.75. Metabolix, Inc. is a bioscience company focused on bringing environmentally friendly solutions to the plastics, chemicals and energy industries. The Company has core capabilities in microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science. It has focused on a family of biopolymers found in nature called polyhydroxyalkanoates (PHAs).
For How Long MBLX’s Gloss will Attract Investors? Find out via this report
Amarin Corporation plc (ADR) (NASDAQ:AMRN) settled -2.21% lower at $1.77 on below -normal volume of 4.44M shares during the last trading day. The stock has its 12-month high at $9.96 and 52-week low price was $1.36. It traded in a range of $1.72 to $1.83 during the last trading day. Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company’s product candidate is AMR101, an ultra-pure omega-3 fatty acid. It is developing AMR101 for the treatment of patients with high triglyceride levels, or hypertriglyceridemia. In September 2011, it filed a New Drug Application (NDA), with the United States Food and Drug Administration (FDA).
Will AMRN Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Delcath Systems, Inc. (NASDAQ:DCTH) was down on high volume, trading at a volume of 3.78M versus its average daily volume of 1.17 million shares. At $0.260, the stock has attained market capitalization of 32.84 million. Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system.
Why Should Investors Buy DCTH After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)